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Moxifloxacin relieves the persistent symptoms of lower 
urinary tract after cessation of ketamine abuse
To the Editor—We read with great interest the recent 
article by Cheung et al,1 in which they described the 
relationship of urinary symptoms and quality of life 
after cessation of ketamine in female abusers. Herein 
we describe a patient with persistent lower urinary 
symptoms after cessation of ketamine. Confusingly, 
his symptoms improved significantly following 
treatment with moxifloxacin. 
 A 24-year-old man was forced to stay in 
a drug rehabilitation centre for 3 months from 
May to July 2011, where he accepted cessation of 
ketamine therapy, as he had a 2-year history of 
severe lower urinary tract symptoms (LUTS) after 
abusing the drug for almost 3 years. There was no 
improvement in symptoms for up to 2 months after 
cessation of ketamine. Two urine cultures grew no 
bacteria, mycoplasma, chlamydia, or acid-fast bacilli 
in the specimens. Nevertheless, treatment with 
moxifloxacin 400 mg daily was commenced for 1 week 
when he accepted this additional treatment for the 
first time. Surprisingly, the patient’s LUTS and quality-
of-life score decreased significantly. In particular, 
his suprapubic pain and dysuria improved markedly 
from the second day of moxifloxacin therapy, and 
1 day after discontinuing the drug they gradually 
recurred and finally returned to the level present 
prior to starting the medication. He was deemed to 
require moxifloxacin 400 mg daily, because without 
such treatment his symptoms recurred and when it 
was restarted they resolved. He still comes to our 
hospital intermittently for moxifloxacin to relieve 
his LUTS. Others have reported no such benefits 
from antibiotic therapy under these circumstances,2,3 
and so the apparent response to treatment with 
moxifloxacin was surprising and difficult to explain. 
Notably, the patient also mentioned experienced 
increasing haematuria for a short period after 
moxifloxacin treatment was initiated, and that he still 
has some dysuria. 
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Management of mercury exposure in Hong Kong Poison 
Centre
To the Editor—In their article on the assessment 
and clinical management of patients with mercury 
poisoning, Fan et al1 studied individuals who were 
non-occupationally exposed to mercury. The authors 
presented the results of a retrospective analysis (41 
persons) who were referred to the Hong Kong Poison 
Information Centre and described their experience 
clearly.1 We were pleased to see that the conclusions 
are fair and in line with those suggested previously.2 
However, two points in the report by Fan et al need 
clarification. First, a sentence of the Results in the 
Abstract states that “Individuals with abnormal tissue 
mercury levels were uncommon.”1 This statement 
incorrectly suggests that both blood and urine 
mercury concentrations may reflect the ‘tissue’ body 
burden of mercury. Instead, both whole blood as well 
as urine mercury levels are not able to identify chronic 
mercury poisoning in exposed individuals.2,3 Several 
reported cases suggest that inconsistencies may 
occur between the patient’s urinary mercury levels 
and symptoms of severe mercury poisoning, even in 
accidental exposure.4 Second, the authors also claim 
that “Removal of existing amalgams without a good 
dental indication is also not advised, as this would 
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Authors’ reply
To the Editor—We agree to Guzzi and Pigatto’s 
comment that the blood and urine level of mercury 
may not reflect the body tissue burden of mercury. 
For mercury-poisoned patients, the best marker for 
body tissue burden should be the concentration 
in the effector organs, ie the brain and kidneys. 
However, in most scenarios, these concentrations are 
not measurable unless at autopsy. It is not practical 
to rely on these measurements to diagnose mercury 
poisoning. Therefore, in the report, we have stressed 
the importance of obtaining a detailed exposure 
history, evaluating the clinical signs and symptoms 
and measuring the blood and urine mercury levels. 
As for Guzzi’s technique of amalgam removal, we 
have no further comments.
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Malpractice claims: corrections
To the Editor—The authors in the Commentary 
“Medical malpractice: prevention is often a better 
strategy” in the October 2011 issue1 would like to 
make two corrections.
 First, the Bolam case was quoted under the 
wrong name of Bolam v Chelsea and Kensington 
Hospital Management Committee [1968] 1 QB 428.1 
It should have been Bolam v Frien Barnet Hospital 
Management Committee [1957] 2 All ER 118. In 
Bolam, McNair J enunciated the legal requirement 
for the standard of care in medical negligence,2 
which is that in accordance with a practice accepted 
as proper by a responsible body of medical men 
skilled in the particular art. In another case, Barnett 
v Chelsea and Kensington Hospital Management 
Committee [1968] 1 QB 428, a watchman arrived in 
the Accident and Emergency nauseated after a cup 
of tea. The casualty doctor simply advised that he 
should see his general practitioner. The man died 5 
hours later from arsenic poisoning. The court found 
that the man would have died anyway because it 
was too late to save him and it was not the casualty 
doctor’s negligence that had caused his death. The 
claimant thus failed to establish causation.2 This 
temporarily raise blood Hg levels through inhaling 
more vapour”. We would like to add that since 2003 
we have developed a new technique for the removal of 
amalgam.5 This procedure makes it possible to control 
the release of mercury vapour during amalgam-
replacement therapy because the entire mercury 
filling is removed en bloc,5 and mercury levels in saliva, 
blood, and urine did not oscillate from baseline levels.
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